BIT’s 4th Annual Congress and Exposition of
Molecular Diagnostics (CEMD-2011)
Theme: Overcome Misinterpretation of Symptoms
Time: September 22-24, 2011
Venue: Beijing International Convention Center
Opening Ceremony
Time: September 22, 2011, 08:30-09:30
Place: Beijing International Convention Center, Beijing, China
Keynote Forum
08:30-09:30
09:30-10:00
Chair' s Opening Remark
Title: Caring Begins with Prevention
Dr. Peter Maag, President, Novartis Diagnostics, USA
Title: Changing the Paradigms of Cancer Screening and Patient Management through
10:00-10:30
Molecular Diagnostics
Dr. Achim Plum, Senior Vice President Corporate Development, Epigenomics AG,
Germany
Title: Serum Protein Biomarkers for Specific, Pre-treatment, Differential Diagnosis and to
10:30-11:00
Monitor Treatment Response of Alzheimer's Disease Patients in Low and High Risk
Populations
Dr. Ira L. Goldknopf, President and CSO, Power3 Medical Products, Inc., USA
Title: TBD
11:00-11:30
Dr. J Chris Houchins, Chief Operating Officer & Sr. Vice President - Clinical Operations,
Arno Therapeutics, USA
11:30-12:00
Representative from Sponsor Organization
12:00-13:00
Industry Lunch Show
18:30-20:30
Welcome Banquet
Track MD1: Breaking Research on Molecular Diagnostics (MDx)
MD100: Functional Genomics, Bioinformatics in Molecular Diagnositics
Day 1, 13:30-15:30, September 22, 2011
Chair:
13:30-13:55
Dr. Xiaolian Gao, Professor and Director of the Keck/IMD NMR Center, the University of
Houston; CSO, LC Sciences, USA
Speech Opportunity Available
Title: Mirfocus Provids Cancer Pathtay Biomaker Mirnas for Cancer Diagnosis
13:55-14:20
Dr.Xiaolian Gao, Professor and Director of the Keck/IMD NMR Center, the University of
Houston; CSO, LC Sciences, USA
Title: Affymetrix High-resolution Genome-wide SNP Array in Clinical Practice
14:20-14:45
Dr. Ying S. Zou, Director of Cytogenetics Laboratory, Pathology Associates Medical
Laboratories, USA
14:45-15:10
Speech Opportunity Available
15:10-15:30
Coffee Break
MD101: Proteomic Profiling of Disease Molecular Diagnostics
Day 1, 13:30-17:10, September 22, 2011
Chair:
13:30-13:55
Dr. Alberto Izzotti, Full Professor, Department of Health Sciences, University of Genoa,
Italy
Speech Opportunity Available
Title: Aquesous Humour Analysis by Antibody Microarray as Diagnostic Tool for Ocular
13:55-14:20
Diseases
Dr. Alberto Izzotti, Full Professor, Department of Health Sciences, University of Genoa,
Italy
Title: A Differential Proteome Screening System for Post-translational
14:20-14:45
Modification–Dependent Transcription Factor Interactions
Dr. Achim Leutz, Professor and Research Group Leader, MDC and BCRT,
Humboldt-University Berlin, Germany
Title: Noninvasive Differential Diagnosis of Hepatitis B and that Induced Liver Cirrhosis
14:45-15:10
and Alcoholic Cirrhosis
Dr. Bishnupada Chatterjee, Professor, West Bengal University of Technology, Sweden
15:10-15:30
15:30-15:55
Coffee Break
Title: Genistein Downregulates Immune signaling Networks through Estrogen Receptor β
Dr. Jacques Vervoort, Professor, Wageningen University, The Netherlands
Title: Investigation of Potential Biomarkers of Socially-significant Human Diseases in
15:55-16:20
Serum Peptidome
Dr. Rustam H. Ziganshin, Senior Scientist, Russian Academy of Sciences, Russia
16:20-16:45
Speech Opportunity Available
16:45-17:10
Speech Opportunity Available
MD102: Metabolomics in Molecular Diagnostics
Day 2, 08:30-10:30, September 23, 2011
Chair:
Dr. Greg Maguire, CEO and Co-Founder, BioRegenerative Sciences, USA
The Left of This Session is Under Development...
MD103: Glycomics and MDx
Day 2, 08:30-10:30, September 23, 2011
Chair:
Call for Chair
The Left of This Session is Under Development...
MD104: Companion Diagnostics-Pharmacogenomic, Predictive and Genetic Testing
Day 2, 13:30-17:10, September 23, 2011
Chair:
13:30-13:55
Call for Chair
Speech Opportunity Available
Title: Creating High-Throughput, Multiplex Molecular Diagnostics for Clinical
13:55-14:20
Pharmacogenomic Use
Dr. Tera Eerkes, Founder and the CSO, iGenix, Inc., USA
14:20-14:45
14:45-15:10
Speech Opportunity Available
Title: A New Molecular Diagnostic Test
Dr. Jean-Luc Margot, Associate Professor, Department of Earth & Space Sciences,
University of California, Los Angeles, USA
15:10-15:30
Coffee Break
Title: Transjudicial Pharmacogenomics Biomarkers for Personalized Justice
15:30-15:55
complementary to Personalized Medicine
Dr. Steven H. Wong, Professor of Pathology and Director, Clinical Chemistry and
Toxicology, Department of Pathology, Wake Forest University School of Medicine, USA
Title: Development of New Generation Antibiotics (Cephalosporins) Using Novel
15:55-16:20
Processing Strategies :- Petri Plates To Plants
Dr. Subir Kundu, Professor & Former Coordinator, School of Biochemical Engineering,
Institute of Technology, Banaras Hindu University, India
Title: Identification of Proteins Involved in Different in Vitro Infective Profiles of Two
16:20-16:45
Trypanosoma Cruzi Zymodeme 3 Strains
Dr. Simone Akemi Kikuchi, Scientist, Oswaldo Cruz Institute, Brazil
Title: MicroRNAs as a Potential Serum Diagnostic Biomarker for Hepatocellular
16:45-17:10
Carcinoma
Dr. Hitender Thakur, Research Associate (ICMR), Department of Biotechnology,
Panjab University Chandigarh, India
MD105: Cytogenetics and FISH
Day 3, 08:30-12:10, September 24, 2011
Chair:
08:30-08:55
Dr. Yi Ning, Associate Professor, and Director of Clinical Cytogenetics Laboratory,
University of Maryland, USA
Speech Opportunity Available
Title: Taking Cytogenetics to Translational Medicine
08:55-09:20
Dr. Yi Ning, Associate Professor and Director of Clinical Cytogenetics Laboratory,
University of Maryland, USA
Title: Genome Profile of BCR/ABLI Positive Leukemia
09:20-09:45
Dr. Ellie Nacheva, Honorary NHS Consultant and Reader in Cytogenetics, University
College London, Medical School, UK
Title: Characterization of Central Nervous System Tumors Combining In Situ Cultures
09:45-10:10
and Molecular Cytogenetic Techniques
Dr. Jin-Yeong Han, Professor and Director, Department of Laboratory Medicine,
Dong-AUniversity College of Medicine, Korea
10:10-10:30
Coffee Break
10:30-10:55
Speech Opportunity Available
10:55-11:20
Title: Cytogenetics to Cytogenomics: Chromosome's FISH and CHIPS
Dr. Alain Bernheim, Director of research at INSERM, France
Title: Utility of Genomic Microarray as a Primary Genomic Screen for Clinically
Significant Imbalances
11:20-11:45
Dr. Sarah T South, Medical Director, ARUP Laboratories, Cytogenetics, Microarray,
Genetic Processing; Assistant Professor, Departmnt of Pediatrics and Pathology,
University of Utah, USA
11:45-12:10
Speech Opportunity Available
Track MD 2: Molecular Diagnostic Technologies
MD201: Mass Spectroscopy, Maldi-TOF and LC-MS in MDx
Day 1, 13:30-15:30, September 22, 2011
Chair:
Call for Chair
The Left of This Session is Under Development...
MD202: Real-time PCR and Other Amplification
Day 2, 08:30-12:10, September 23, 2011
Chair:
08:30-08:55
08:55-09:20
09:20-09:45
Dr. Junko Stevens, R&D Director, Life Technologies, USA
Speech Opportunity Available
Title: Epigenetics Tools for Molecular Diagnostics
Dr. Junko Stevens, R&D Director, Life Technologies, USA
Title: High throughput Single Cell Expression Profiling
Dr. Mikael Kubista, CEO, TATAA Biocenter AB, Sweden
Title: Quantitative Real-time PCR as a Prognostic Tool for Infectious Diseases
09:45-10:10
Dr. Max Maurin, Professor of clinical microbiology; Director of the Clinical Microbiology,
Department of Grenoble University Hospital, Joseph Fourier University, France
10:10-10:30
Coffee Break
10:30-10:55
Speech Opportunity Available
10:55-11:20
Title: DNA Decontamination Procedures in Diagnostic PCR Applications
Dr. Morten Elde, Head of Application Development, Arcticzymes AS, Norway
Title: Detection of Viable Legionella Pneumophila Using Real Time
11:20-11:45
Transcription-Medicated Amplification Integrated in a Point-of-Testing System
Dr. Patrick Genyan Yang, Senior Service Fellow, Centers for Disease Control and
Prevention, USA
Title: The Use of Real Time PCR in Breast Cancer Research
11:45-12:10
Dr. Jennifer Gjerde, Post Doctoral, University of Bergen, Norway
MD203: Nonamplified Probe-Based Assays and AmpliChip CYP450 Test
Day 2, 08:30-10:30, September 23, 2011
Chair:
08:30-08:55
Dr. Kuo-Chen Chou, Chief Scientist & Professor, Gordon Life Science Institute, USA
Speech Opportunity Available
Title: Cellular and Molecular Defects Underlying Excess Ovarian Androgen Biosynthesis
08:55-09:20
in Polycystic Ovarian Syndrome (PCOS)
Dr. Jan McAllister, Professor, Department of Pathology and OB/Gyn, Penn State
Hershey College of Medicine, USA
09:20-09:45
09:45-10:10
10:10-10:30
Speech Opportunity Available
Title: TBD
Dr. Kuo-Chen Chou, Chief Scientist & Professor, Gordon Life Science Institute, USA
Coffee Break
MD204: Array, Biochips and Multiplex Assays
Day 2, 13:30-17:10, September 23, 2011
Chair:
Dr. Thanos Mitrelias, President, CEO and Founder, Cambridge BioMagnetics;
Scientist, the Cavendish Laboratory, the University of Cambridge Ltd., UK
13:30-13:55
13:55-14:20
Speech Opportunity Available
Title: Multiplex-IVD Meets Low-volume Dispensing: The Best of Both Worlds
Dr. Gunter J. Bauer, Chief Business Officer, Scienion AG, Germany
Title: A Versatile, one Gene-family Based Multiplex Assay for the Simple and Rapid
14:20-14:45
Identification of Plant Ingredients in Foodstuffs
Dr. Anna Paola Casazza, Fixed-term Researcher, National Research Council of Italy
and Institute of Agricultural Biology and Biotechnology, Italy
Title: Magnetic Lab-on-a-chip Devices for Multiplexed Clinical Diagnostics
14:45-15:10
Dr. Thanos Mitrelias, President, CEO and Founder, Cambridge BioMagnetics;
Scientist, the Cavendish Laboratory, the University of Cambridge Ltd., UK
15:10-15:30
Coffee Break
15:30-15:55
Speech Opportunity Available
Title: Innovation Technology to Engineer 3D Living Organs as Intelligent Diagnostic
15:55-16:20
Tools
Dr. Hossein Hosseinkhani, Associate Professor, Biomedical Engineering, Yang Ming
University, Taiwan
Title: Rhizobia Core and Divergent Gene Sets Related to Stress Environment Evaluated
16:20-16:45
by Comparative Genome Hybridization.
Dr. Marina Roumiantseva, Senior. Sc. Researcher, Project Manager and Group Leader,
All-Russian Research Institute for Agricultural Microbiology, Russia
Title: Single DNA Molecule Biochip
16:45-17:10
Dr. Laurence Salome, Researcher, Institute of Pharmacology and Structural Biology,
France
MD205: Nanotechnology and Multicolor Quantum Dots in Molecular Diagnostics
Day 2, 13:30-15:30, September 23, 2011
Dr. Ren’ an Wu, Professor of Chemistry, CAS Key Laboratory of Separation Sciences for
Chair:
Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of
Sciences (CAS), China
13:30-13:55
Speech Opportunity Available
Title: Potential Peptide Biomarker Analysis by Advanced Materials
13:55-14:20
Dr. Ren’ an Wu, Professor of Chemistry, CAS Key Laboratory of Separation Sciences for
Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of
Sciences (CAS), China
Title: Oral Premalignant Lesions with 5-ALA Induced PpIX Fluorescence
14:20-14:45
Dr. Keng-Shiang Huang, Guest Editor, International Journal of Technology and Human
Interaction; Assistant Professor, The School of Chinese Medicine for
Post-Baccalaureate, I-Shou University, Taiwan
Title: Synthesis and Biocompatibility of Quantum Dots
14:45-15:10
Dr. William W. Yu, Professor and Research Scientist, Jilin University and Rice
University, China, USA
15:10-15:30
Coffee Break
MD206: Single Molecule Biology and Single Cell Analysis for MDx
Day 3, 08:30-10:30, September 24, 2011
Chair:
08:30-08:55
08:55-09:20
09:20-09:45
Dr. Ramesh Ramakrishnan, Director, Fluidigm Corp., USA
Speech Opportunity Available
Title: Digital PCR: a Powerful Tool in Single Molecule Analysis
Dr. Ramesh Ramakrishnan, Director, Fluidigm Corp., USA
Speech Opportunity Available
Title: Sensitivity Enhancement in Electrochemical Immunosensors by Use of Nano
09:45-10:10
Particles
Dr. Vepa Kameswara Rao, Scientist & Joint Director and Head, Biosensor
Developmentdivision, Defence Research & Development Establishmnent, India
10:10-10:30
Coffee Break
MD207: Next Generation Nucleic Acid-Based Diagnostics Technologies
Day 3, 08:30-10:30, September 24, 2011
Chair:
08:30-08:55
08:55-09:20
Dr. Charles R. Cantor, Founder and CSO, SEQUENOM, Inc., USA
Title: Personalized Biomarkers: Moving from Discovery to Potential Clinical Applications
Dr. Charles R. Cantor, Founder and CSO, SEQUENOM, Inc., USA
Speech Opportunity Available
Title: Fiber-Optic Particle Plasmon Resonance Sensor for Label-Free Detection of
09:20-09:45
Nucleic Acids
Dr. Lai-Kwan Chau, Professor and Director, Department of Chemistry and Biochemistry
and Center for Nano Bio-Detection, National Chung Cheng University, Taiwan
Title: A Spinning-multilayered Disk Biosensor
09:45-10:10
Dr. Penmetcha Kumar, Senior Research Scientist, National Institute of Advanced
Industrial Science and Technology (AIST), Japan
10:10-10:30
Coffee Break
MD208: DNA Methylation Assays
Day 3, 13:30-15:30, September 24, 2011
Chair:
13:30-13:55
Call for Chair
Speech Opportunity Available
Title: DNA Methylation of Human Height Genes
13:55-14:20
Dr. Saverio Alberti, Professor, Unit of Cancer Pathology, Center for Excellence in
Research on Aging, University “G. D’ Annunzio”, Italy
Title: Metabolism and DNA Methylation Deviations in the Pathogenesis of Disease
14:20-14:45
Dr. Piet J. Pretorius, Professor, Division of Biochemistry, North-West University, South
Africa
Title: Quantitative Analysis of DNA Methylation Variation in Normal and Tumor Tissues
14:45-15:10
Dr. Hehuang Xie, Research Assistant Professor, Cancer Biology and Epigenomics
Program, Children's Memorial Research Center, Northwestern University's Feinberge,
USA
15:10-15:30
Coffee Break
MD209: Next Generation Nucleic Acid-Based Diagnostics Technologies
Day 3, 13:30-17:10, September 24, 2011
Chair:
Dr. Willy Valdivia-Granda, CEO, Orion Integrated Biosciences, Inc., USA
13:30-13:55
Title: Next Generation Sequencing for Molecular Diagnostics of Pathogens
Dr. Willy Valdivia-Granda, CEO, Orion Integrated Biosciences, Inc., USA
Title: Tumor Heterogeneity and Progression Assayed by NextGen Sequencing of
13:55-14:20
Individual Cancer Cells
Dr. James B. Hicks, Professor, Cold Spring Harbor Laboratory, USA
14:20-14:45
14:45-15:10
15:10-15:30
Speech Opportunity Available
Title: In Vivo Imaging of DNA Damage and Repair
Dr. Yanming Wang, Associate Professor, Case Western Reserve University, USA
Coffee Break
Title: Evolution of Next-generation Sequencing and Its Application in Microflora Study -
15:30-15:55
Comparative Study of Gut Microflora in Children from Europe and Rural Africa
Dr. Jean-Pol Detiffe, Founder and CEO, DNAVISION SA, Belgium
Title: Application of Next Generation Sequencing in Human Genetics
15:55-16:20
Mr. Stefan Kotschote, Deputy Head of Laboratory, IMGM Laboratories GmbH,
Germany
16:20-16:45
Speech Opportunity Available
16:45-17:10
Speech Opportunity Available
MD210: microRNA, Gene Expression Profiling
Day 3, 13:30-15:30, September 24, 2011
Chair:
13:30-13:55
Call for Chair
Speech Opportunity Available
Title: Inolvement of miRNA in the Development of HIV-1 Associated Neurocogntive
13:55-14:20
Disorders
Dr. Bassel E. Sawaya, Associate Professor, College of Science and Technology,
Temple University, USA
Title: Elucidating the Role of microRNA in Colorectal Cancer
14:20-14:45
Dr. Sabariah Abdul Rahman, Professor and Head, UPM-MAKNA Cancer Resaerch
Laboratory, Institute of Biosciences, Universiti Putra Malaysia, Malaysia
Title: Evaluation the Liver Enzymes Gene Expression after Chemical Induced Injury in
14:45-15:10
Rats Treated with Phenolic Compounds Antioxidants
Dr. Jorge Mancini-Filho, Professor and Director, University of Sao Paulo, Brazil
15:10-15:30
Coffee Break
Track MD3: Molecular Diagnostics on Cancer
MD300: Molecular Diagnostic Screening Test for Cancer
Day 1, 13:30-17:10, September 22, 2011
Chair:
13:30-13:55
13:55-14:20
Dr. Zhong Chen, Professor of Pediatrics and Pathology, University of Utah School of
Medicine; CTO, China Medical Technologies, Inc., USA
Title: Significance of Circulating Tumor Cell detection for Cancer Molecular Diagnosis
Dr. Fyllis Tafas, CTO and Founder, Ikonisys Inc., USA
Speech Opportunity Available
Title: Molecular Diagnostics and Personalized Medicine in Cancer
14:20-14:45
Dr. Zhong Chen, Professor of Pediatrics and Pathology, University of Utah School of
Medicine; CTO, China Medical Technologies, Inc., USA
Title: Using NF-κB as a Molecular Target for Diagnosis and Therapy of Human
14:45-15:10
Hepatoma with Tumor-Bearing Animal Model
Dr. Jeng-Jong Hwang, Professor, Department of Biomedical Imaging and Radiological
Sciences (BIRS), National Yang-Ming University, Taiwan
15:10-15:30
Coffee Break
15:30-15:55
Speech Opportunity Available
Title: Molecular Diagnosis for Head and Neck Cancer
15:55-16:20
Dr. Wantao Chen, Director and Professor, Ninth People's Hospital, Shanghai Jiao Tong
University School of Medicine, China
Title: Milestones in Molecular Hematology
16:20-16:45
Dr. Salem H Khalil, Consultant Hematopathologist and Clinical Assistant Professor,
King Saud University; Assistant Professor, Al Faisal University, Saudi Arabia
16:45-17:10
Title: The Neoplasm of Giant Cell Tumor of Bone
Dr. Isabella Mak, Research Coordinator, McMaster University, Canada
MD301: Gynecologic Tumors: Breast, Cervical, Endometrial and Ovarian Cancers
Day 1, 13:30-16:20, September 22, 2011
Chair:
13:30-13:55
13:55-14:20
Dr. Giorgio Secreto, Professor and Director, Hormone Research Laboratory, National
Cancer Institute, Italy
Title: OVA1 as an Aid in Assessing Ovarian Tumors
Dr. Eric Fung, Senior VP and CSO, Vermillion Inc., USA
Speech Opportunity Available
Title: Androgens and Androgen Receptors in Women with Breast Cancer
14:20-14:45
Dr. Giorgio Secreto, Professor and Director, Hormone Research Laboratory, National
Cancer Institute, Italy
Title: Molecular Characterization of Individually Isolated Cancer Cells
14:45-15:10
Dr. Oystein Fodstad, Professor and Director, Mitchell Cancer Institute, University of
South Alabama, Norway
15:10-15:30
Coffee Break
Title: CXCL12 Expression by Healthy and Malignant Cells
15:30-15:55
Dr. Veronique Machelon, Professor and Director, INSERM, Paris-Sud University,
France
Title: Bridge the Gap from Biomarker Discovery to Clinical Diagnostics – Lessons
Learned from OVA1, the First FDA-cleared in Vitro Diagnostic Multivariate Index Assay
15:55-16:20
(IVDMIA) of Protein Biomarkers.
Dr. Zhen Zhang, Associate Professor of Pathology and Oncology; Associate Director,
Center for Biomarker Discovery and Translation, Johns Hopkins University School of
Medicine, USA
MD302: Colon, Colorectal Cancers and K-RAS Mutations
Day 2, 08:30-10:30, September 23, 2011
Chair:
08:30-08:55
08:55-09:20
Call for Chair
Speech Opportunity Available
Title: Molecular Diagnostics for Colon Cancer: Tissue Discovery to Blood Testing
Dr. Lawrence C. LaPointe, CEO, Clinical Genomics Pty Ltd., Australia
Title: An Immunoassay for Human Aspartyl (Asparaginyl) β-Hydroxylase (HAAH), a
09:20-09:45
Novel Cancer Serum Biomarker: Diagnosis of Colon Cancer
Dr. Mahmood Moshiri, President/CEO, Panacea Global Inc., Canada
Title: Whole Genome Profiling of Serum microRNAs in diagnosis and Prognosis of
09:45-10:10
Cancer in Humans
Dr. Anju Preet, Cancer Research Scientist, Lombardi Comprehensive Cancer Center,
Georgetown University, USA
10:10-10:30
Coffee Break
MD303: Leukemia, Lymphoma, and Chronic Myeloblastic Leukemia
Day 2, 08:30-12:10, September 23, 2011
Chair:
08:30-08:55
08:55-09:20
Dr. Elliot Epner, Professor of Medicine, Penn State Hershey Cancer Institute, USA
Speech Opportunity Available
Title: Combined Epigenetic and Immunotherapy for B Cell Malignancies
Dr. Elliot Epner, Professor of Medicine, Penn State Hershey Cancer Institute, USA
Title: Contribution of Flow Cytometry to Diagnosis of Skin Lymphoid Lesions
09:20-09:45
Dr. Hong Wu, Associate Professor, Department of Pathology, Fox Chase Cancer
Center, USA
Title: Molecular Mechanism of Suboptimal Health-glycobiology Study
09:45-10:10
Dr. Wei Wang, Professor and Dean, School of Public Health and Family Medicine,
Capital Medical University; College of Life Sciences, Graduate University, Chinese
Academy of Sciences, China
10:10-10:30
Coffee Break
10:30-10:55
Speech Opportunity Available
Title: hCLP46, A Potential Biomarker Associated With Acute Leukemia
10:55-11:20
Dr. Youxin Wang, Assistant Professor, School of Public Health and Family Medicine,
Capital Medical University, China
Title: Expression of Inhibitor Apoptotic Protein (IAP) Livin/BIRC7 in Acute Leukemia in
11:20-11:45
Adults: Correlation with Prognostic Factors and Outcome
Dr. Hala El Mosalamy, Professor and Head of Biochemistry Department and Ex. Vice of
Dean for Community and Environmental Affairs, Egypt
Title: Genome-Wide Analysis of Chromosomal Abnormalities in Acute Lymphoblastic
11:45-12:10
Leukemia
Dr. Guangyu Gu, Fellow, Clinical Cytogenetics, Department of Pathology, ARUP
Laboratories, University of Utah, USA
MD304: CNS Tumors
Day 2, 13:30-15:30, September 23, 2011
Chair:
Call for Chair
Title: Cancer Clinical Diagnostic Applications with SNP Arrays: Clinical Utility and Case
13:30-13:55
Studies
Dr. Robert Klein, CEO, iKaryos Diagnostics, USA
13:55-14:20
14:20-14:45
Speech Opportunity Available
Title: Nucleic Acids within Microvesicles as a Blood Based Diagnostics for Cancer
Dr. Johan Skog, Director of Research, Exosome Diagnostics, USA
Title: Molecular Fidelity of Orthotopic Xenograft Mouse Models of Pediatrics Brain
14:45-15:10
Tumors
Dr. Hon-chiu Eastwood Leung, Assistant Professor, Department of Molecular and
Cellular Biology, Baylor College of Medicine, USA
15:10-15:30
Coffee Break
MD305: Melanoma and Sarcoma
Day 2, 13:30-15:30, September 23, 2011
Chair:
Dr. Thomas Andrew Braun, CEO, President and Director, Verisante Technology Inc.,
USA
Title: Rapid Raman Spectroscopy for Melanoma Screening
13:30-13:55
Dr. Thomas Andrew Braun, CEO, President and Director, Verisante Technology Inc.,
USA
13:55-14:20
14:20-14:45
Speech Opportunity Available
Title: Alternative Treatment Strategies in Sarcoma
Dr. Robin L. Jones, Associate Professor, University of Washington, USA
Title: Melanoma Adjuvant Therapy
14:45-15:10
Dr. Ahmad Tarhini, Assistant Professor of Medicine, Clinical and Translational Science,
University of Pittsburgh School of Medicine, USA
15:10-15:30
Coffee Break
MD306: Pancreatic and Prostate Cancer
Day 3, 13:30-15:30, September 24, 2011
Chair:
13:30-13:55
Call for Chair
Speech Opportunity Available
Title: Identification of cell-surface proteins for targeted pancreatic cancer therapies and
13:55-14:20
imaging
Dr. Randy S. Haun, Associate Professor, Department of Pharmaceutical Sciences,
University of Arkansas for Medical Sciences, USA
14:20-14:45
Speech Opportunity Available
Title: Has the Prostate Health Index (PHI) a Role in Biological Screening of Prostate
14:45-15:10
Cancer?、
Dr. Thomas Guery, Biochemical Laboratory, Hospital Group of Catholic Institute of Lille,
《 Groupe Hospitalier de l’Institut Catholique de Lille》, France
15:10-15:30
Coffee Break
MD307: Liver, Renal and Bladder Cancers
Day 3, 13:30-15:30, September 24, 2011
Chair:
13:30-13:55
13:55-14:20
Call for Chair
Speech Opportunity Available
Title: The Strand Virtual Liver Project
Dr. Vijay Chandru, Chairman & CEO, Strand Life Sciences Private Limited, India
Title: Post-Bilharzial Urinary Bladder Carcinomain Egypt: Special Pattern and a Fading
14:20-14:45
Problem
Dr. Gamal M Saied, Professor of General Surgery, Faculty of Medicine, Cairo University,
Egypt
Title: Screening for Prostate Cancer
14:45-15:10
Dr. Ahmad Shabsigh, Assistant Professor in Urologic Oncology, Department of Urology,
The Ohio State University, USA
15:10-15:30
Coffee Break
MD308: Molecular Diagnostics of Lymphoid Malignancies
Day 3, 13:30-15:30, September 24, 2011
Chair:
13:30-13:55
Call for Chair
Speech Opportunity Available
Title: B-cell Neoplasia in the Context of HCV Infection: A Distinct Entity?
13:55-14:20
Dr. Massimo Libra, Aggregate Professor, Department of Biomedical Sciences,
University of Catania, Italy
Title: Gene expression Profiling for Lymphoma Diagnosis and Prognostication
14:20-14:45
Dr. Pier Paolo Piccaluga, Associate Professor, Molecular Pathology Laboratory,
Hematopathology Unit, S. Orsola-Malpighi Hospital, University of Bologna, Italy
Title: Use of Clonality Tests in the Diagnosis of Lymphoproliferative Disorders
14:45-15:10
Dr. Anna Gazzola, Molecular Biotechnologist, Hematopathology Unit, S.
Orsola-Malpighi Hospital, University of Bologna, Italy
15:10-15:30
Coffee Break
MD309: Lung Cancers, Glioblastoma and Other Cancers
Day 3, 13:30-17:10, September 24, 2011
Chair:
13:30-13:55
Call for Chair
Speech Opportunity Available
Title: A Serum Diagnostic for Lung Cancer Based on the Novel Tumor Marker Human
13:55-14:20
Aspartyl (Asparaginyl) β-Hydroxylase
Dr. Hossein A. Ghanbari, CSO and Chairman, Panacea Global Inc., Canada
14:20-14:45
Speech Opportunity Available
Title: Molecular Mechanism and Clinical Significance of Twist1-induced Stem Like
14:45-15:10
Properties in Head and Neck Cancer
Dr. Muh-Hwa Yang, Associate Professor, Institute of Clinical Medicine, National
Yang-Ming University, Taiwan
15:10-15:30
Coffee Break
15: 30-15:55
Speech Opportunity Available
Title: Smart Amplification Process as a Simple Solution to Detect Clinically Important
15:55-16:20
SNPs and Mutations
Dr. Alexander Lezhava, Unit Leader, RIKEN Yokohama Institute, Japan
Title: New Developments in the Studies of Mesothelioma
16:20-16:45
Dr. Haining Yang, Assistant Professor, John A. Burns School of Medicine, University of
Hawaii, USA
Title: CT Guided Lung Procedures
16:45-17:10
Dr. Marcos Duarte Guimaraes, Radiologist, Department of Radiology, Hospital A. C.
Camargo, Brazil
MD310: Companion Diagnostic Tests for Cancer Therapeutics
Day 3, 13:30-15:30, September 24, 2011
Chair:
13:30-13:55
13:55-14:20
14:20-14:45
Dr. Yuling Luo, Founder, President & CEO, Advanced Cell Diagnostics, Inc., USA
Speech Opportunity Available
Title: TBD
Dr. Martha C. Townsend, President, Market Ready Rx, Inc., USA
Speech Opportunity Available
Title: Sea Change - Co-Development, Collaboration, and Agency Coordination in the
14:45-15:10
New Era of Companion Diagnostics for Cancer Therapeutics
Dr. Eric Lawson, Vice President, Compliance & Regulatory Affairs, Metamark Genetics,
Inc., USA
15:10-15:30
Coffee Break
Track MD4: Molecular Diagnostics for Infectious Diseases
MD400: Virus Infections
Day 1, 13:30-17:10, September 22, 2011
Chair:
13:30-13:55
Dr. Steve Amato, Managing Director, tJun 17 Life Sciences, LLC, USA
Speech Opportunity Available
Title: The Evolving Diagnostics Market Access Landscape in the US: Reimbursement
13:55-14:20
and Pricing Issues
Dr. Steve Amato, Managing Director, tJun 17 Life Sciences, LLC, USA
Title: MicrorRNAs in Viral Infections- Diagnosis and Therpy
14:20-14:45
Dr. Zvi Bentwich, Professor of Virology and Immunology and Head of the Center for
Emerging Tropical Diseases and AIDS at the Ben Gurion University, Israel
Title: The Epidemic of HIV in China and Implications for Drug Interactions and New
14:45-15:10
Treatments for HIV
Dr. David A. Flockhart, Professor and Chief, Division of Clinical Pharmacology, Indiana
University, USA
15:10-15:30
Coffee Break
Title: Host Gene Expression for Pre-symptomatic Diagnosis of Respiratory Viral
15: 30-15:55
Infections
Dr. Christopher W. Woods, Associate Professor of Medicine, Pathology, and Global
Health; Director, MSc-Global Health, Duke University Medical Center, USA
Title: Serum Lipoprotein Biomarkers and Hemmorrhagic Fever and Renal Syndrome
15:55-16:20
and Interstial Pumonary Fibrosis
Dr. Kyung-Hyun Cho, Professor, School of Biotechnology, Yeungnam University, Korea
Title: Molecular identification and Typing of Clinical Varicella–Zoster Virus from Kuwait
16: 20-16:45
Dr. Jafar A. Qasem, Chairman, Department of Applied Medical Sciences, Public
Authority for Applied Education and Training (PAAET), College of Health Sciences,
Kuwait
Title: The Role of Second Generation Non-Nucleoside Reverse Transcriptase Inhibitors
16:45-17:10
(NNRTIs) in HIV-1 Antiretroviral Therapy
Dr. Eugene Asahchop, Jewish General Hospital/McGill AIDS Center, Canada
MD401: Bacterial & Fungal Infections
Day 1, 13:30-15:30, September 23, 2011
Chair:
13:30-13:55
Call for Chair
Speech Opportunity Available
Title: Non-Invasive Molecular Dignostic Approach for Hemathologic Malignancy Patients
13:55-14:20
Whom at High Risk of Invasive Fungal Infections
Dr. Ray Y Hachem, Associate Professor, The University of Texas M. D. Anderson
Cancer Center, USA
Title: Role of PCR-based Molecular Assays in the Early Diagnosis of Invasive Fungal
14:20-14:45
Infections
Dr. Pei Pei Chong, Associate Professor, Department of Biomedical Science, Faculty of
Medicine and Health Sciences, University Putra, Malaysia
14:45-15:10
Speech Opportunity Available
15:10-15:30
Coffee Break
MD402: Parasite Infections, and Emerging TB and Malaria
Day 2, 08:30-10:30, September 23, 2011
Dr. Kin-Mu Lee, Professor and Director, Institute of Medical Biotechnology and Institute
Chair:
of pharmaceutical Science and Technology, Central Taiwan University of Science and
Technology, Taiwan
08:30-08:55
Speech Opportunity Available
Title: Molecular Cloning and Characterization of the 53kDa Excretory/Secretory
Glycoprotein (gp53) and Tropomyosin Antigens of Trichinella Spiralis
08:55-09:20
Dr. Kin-Mu Lee, Professor and Director, Institute of Medical Biotechnology and Institute
of pharmaceutical Science and Technology, Central Taiwan University of Science and
Technology, Taiwan
Title: The Plasmodium Falciparum Serine Repeat Antigen, A Malaria Vaccine Candidate
09:20-09:45
Dr. Toshihiro Horii, Professor, Department of Molecular Protozoology, Research
Institute for Microbial Diseases, Osaka University, Japan
Title: Rapid Detection of Mycobacteria Directly from Stained Smear Positive Slides
09:45-10:10
Using DNA Strip Technology
Dr. Dhanida Rienthong, Deputy Head of NRL and SRL of Tuberculosis, Thailand
10:10-10:30
Coffee Break
MD403: Genetic Testing for Inherited Disorders and Prenatal Diagnostics
Day 2, 13:30-15:30, September 24, 2011
Chair:
13:30-13:55
Call for Chair
Speech Opportunity Available
Title: Improving Outcomes in Corneal Transplant Surgery on Children and Infants
13:55-14:20
Dr. Gerald W Zaidman, Professor and Director of Ophthalmology and Vice-Chairman,
New York Medical College, USA
14:20-14:45
Speech Opportunity Available
Title: Development of Quantitative-fluorescence Polymerase Chain Reaction (QFPCR)
14:45-15:10
for the Rapid Prenatal Diagnosis of Common Chromosomal Aneuploidies in 1,000
Samples in Singapore
Dr. Sherry Ho, Postdoctorate Fellow, National University Health System, Singapore
15:10-15:30
Coffee Break
MD404: Hemostasis and Thrombosis
Day 3, 8:30-10:30, September 24, 2011
Chair:
08:30-08:55
Dr. Mike Gerometta, Director, Research and Product Development, ThromboView,
Agenix Ltd, Australia
Speech Opportunity Available
Title: Potential Gold Standard In Vivo Detection of VTE in Humans using an Anti-Fibrin
Humanized Monoclonal Antibody Protein Fragment Conjugated with Technetium-99m
08:55-09:20
and SPECT: ThromboView
Dr. Mike Gerometta, Director, Research and Product Development, ThromboView,
Agenix Ltd, Australia
Title: Thrombin Generation Analysis in Patients with Thrombosis or Arterial Vascular
09:20-09:45
Disease
Dr. Hugo ten Cate, Professor, Department of Internal Medicine, University of Maastricht,
The Netherlands
09:45-10:10
Speech Opportunity Available
10:10-10:30
Coffee Break
Track MD5: Molecular Diagnostics for Other Severe Diseases
MD500: Molecular Diagnositics on Genetic Disorders
Day 1, 13:30-15:30, September 22, 2011
Chair:
13:30-13:55
Call for Chair
Speech Opportunity Available
Title: Dealing with Genetic Susceptibility of Radiation Induced Brain Tumors
13:55-14:20
Dr. Siegal Sadetzki, Head, Cancer & Radiation Epidemiology Unit, Gertner Institute,
Chaim Sheba Medical Center, Israel
Title: Role of GLUT-4 and TNF-alpha in Diabetes
14:20-14:45
Dr. Mandumpal Chacko Sabu, Faculty of Pharmaceutical Sciences, University College
Sedaya International, Malaysia
14:45-15:10
Speech Opportunity Available
15:10-15:30
Coffee Break
MD501: Diagnostic Biomarkers for CNS Diseases
Day 1, 13:30-17:10, September 22, 2011
Chair:
Dr. Ira L. Goldknopf, President and CSO, Power3 Medical Products, Inc., USA
Title: Serum Protein Biomarkers for Specific, Pre-treatment, Differential Diagnosis and to
13:30-13:55
Monitor Treatment Response of Alzheimer's Disease Patients in Low and High Risk
Populations
Dr. Ira L. Goldknopf, President and CSO, Power3 Medical Products, Inc., USA
Title: CNS Disease Biomarker Study (AD or PD)
13:55-14:20
Dr. Wang Xiaoliang, Professor of Pharmacology, Institute of Materia Medica, Chinese
Academy of Medical Sciences, China
14:20-14:45
14:45-15:10
Speech Opportunity Available
Title: Pteridine Metabolic Patterns as Diagnostic Biomarkers for Neurotransmitter
Diseases
Dr. Haruo Shintaku, Professor, Department of Pediatrics, Osaka City University
Graduate School of Medicine, Japan
15:10-15:25
Coffee Break
Title: Vascular Targets in Alzheimer's Disease
15:30-15:55
Dr. Samir Kumar-Singh, Professor of Molecular Neuropatholgy, University of Antwerp,
Belgiums
15:55-16:20
Speech Opportunity Available
Title: Multiple Sclerosis: Success of Biomarkers for Early Detection and Possible
16:20-16:45
Treatment
Dr. Arati A. Inamdar, Research Associate, Rutgers University, USA
Title: Biomarkers of Brain Damage and Postoperative Cognitive Dysfunction (POCD) in
16:45-17:10
Orthopaedic Patients after Big Joints Arthroplasties
Dr. Dariusz Tomaszewski, Specialist, Military Institute of the Health Services, Poland
MD502: Psychiatric and Neurodegenerative Diseases
Day 2, 08:30-10:30, September 23, 2011
Dr. Xiaohua Li, Tate Jordan Thomas Associate Professor of Psychiatry, Director,
Chair:
Behavioral Neurobiology; Vice Chair for Research, Department of Psychiatry, University
of Alabama at Birmingham, UK
08:30-08:55
Speech Opportunity Available
Title: Neuroimaging in Diagnosis and Monitoring Treatment Response in Alzheimer's
08:55-09:20
Disease and Related Disorders
Dr. Claude Wischik, Executive Chairman and Founder, TauRx Therapeutics, UK
Title: Glycogen Synthase Kinase-3 as a Peripheral Marker for Diagnosis and Treatment
of Mood Disorders
09:20-09:45
Dr. Xiaohua Li, Tate Jordan Thomas Associate Professor of Psychiatry, Director,
Behavioral Neurobiology; Vice Chair for Research, Department of Psychiatry, University
of Alabama at Birmingham, UK
Title: Neurorprotective Strategies in the Experimental Model of Huntinton’s Diseases
09:45-10:10
Dr. Anil Kumar, Associate Professor, University Institute of Pharmaceutical Sciences,
Centre of Advanced Study, Panjab University, India
10:10-10:30
Coffee Break
MD503: Cardivascular and Cerebrovascular Diseases
Day 3, 8:30-12:10, September 24, 2011
Chair:
08:30-08:55
Call for Chair
Speech Opportunity Available
Title: The F11R/JAM-A Protein: A Critcal Factor in Atherogenesis and a Marker for
08:55-09:20
Cardiovascular Disease
Dr. Elizabeth Kornecki, Professor of Medicine and Cell Biology/Anatomy, SUNY
Downstate Medical Center, USA
Title: Valvular Heart Disease in Patients with CKD (chronic kidney dysfunction)
09:20-09:45
Dr. Qi Qian, Consultant, Division of Nephrology & Hypertension, Department of
Medicine; Head, Acid-base Electrolyte Specialty Clinic, College of Medicine, USA
09:45-10:10
Title: Molecular Therapy and Diagnostics for Life-threatening Vasospasm
Dr. Sei Kobayashi, Professor and Chairman, Department of Molecular Physiology and
Medical Bioregulation, Yamaguchi University Graduate School of Medicine, Japan
10:10-10:30
Coffee Break
Title: Clinical Imaging of the Endothelial Glycocalyx: A Non-invasive Diagnostic Tool to
10:30-10:55
Assess Cardiovascular Risk
Dr. Hans Vink, Associate Professor, Department of Physiology, Maastricht University,
the Netherlands
Title: Diastolic Heart Failure in the Post Openrative Heart
10:55-11:20
Dr. Ahmed Alsaddique, Professor & Head of Cardiac Surgrey, King Fahad Cardiac
Center & College of Medicine, King Saud University, Saudi Arabia
Title: One-step Immunoassay to Non-invasively Detect Biomarkers for Heart Disease
11:20-11:45
Dr. Chamindie Punyadeera, Smart Futures Senior Research Fellow, Australian Institute
for Bioengineering and Nanotechnology, The University of Queensland, Australia
11:45-12:10
Speech Opportunity Available
MD504: Arthritis and Severe Inflammations
Day 2, 13:30-15:30, September 23, 2011
Chair:
13:30-13:55
Call for Chair
Speech Opportunity Available
Title: The Colony Stimulating Factors as Inflammatory Targets
13:55-14:20
Dr. John A. Hamilton, Professor, Department of Medicine, University of Melbourne,
Australia
Title: Mucosal Biomarkers of Inflammatory Bowel Disease
14:20-14:45
Dr. Jon Florholmen, Professor and Head, Research Group of Gastroenterology and
Nutrition, Institute of Clinical Medicine, University of Tromso, Norway
14:45-15:10
Speech Opportunity Available
15:10-15:30
Coffee Break
MD505: Cystic and Liver Fibrosis
Day 2, 13:30-15:30, September 23, 2011
Chair:
13:30-13:55
Dr. Axel M. Gressner, Professor, The German Society for Clinical Chemistry and
Laboratory Medicine (DGKL), Germany
Speech Opportunity Available
Title: Recent Advances in the Non-invasive Diagnostics and Follow-up of Fibrogenic
13:55-14:20
Liver Diseases
Dr. Axel M. Gressner, Professor, The German Society for Clinical Chemistry and
Laboratory Medicine(DGKL), Germany
Title: Novel Molecular Approaches to the Diagnosis of Autosomal Dominant Polycystic
Kidney Disease
14:20-14:45
Dr. Arlene Chapman, Professor of Medicine; Assistant Fellowship Program Director
Renal Division; Co-Principal Investigator Atlanta Clinical and Translational Science
Institute; Program Director Clinical Interactions Network, USA
Title: Can Biochemical Markers Predict Oesophageal Varices in Patients with Liver
14:45-15:10
Crrhosis?
Dr. Tahiri Joutei Hassani Mohammed, Senior Gastro Enterologist, IBN ROCHD
university Hospital in Casablanca, France
15:10-15:30
Coffee Break
MD506: Biomarkers in Ovarian, Renal, and Bladder Diseases, Multiple Sclerosis, SLE, and Arthritis
Day 3, 08:30-10:30, September 24, 2011
Chair:
08:30-08:55
Call for Chair
Speech Opportunity Available
Title: Markers in Bladder Cancer: An Update
08:55-09:20
Dr. Vincenzo Altieri, Professor of Urology and Head, Oncologic Urology and
Endourology Unit
"Federico II" University, Medical School, Italy
09:20-09:45
09:45-10:10
10:10-10:30
Speech Opportunity Available
Title: New Approach to Diagnose Mild Acute Kidney Injury
Dr. Karina Soto, Department of Nephrology, Hospital Fernando Fonseca, Portugal
Coffee Break
MD507: Endocrine and Metabolic Diseases: Diabetes and Obesity
Day 3, 08:30-10:30, September 24, 2011
Chair:
08:30-08:55
Dr. Lingyun Wu, Professor, Department of Pharmacology, College of Medicine; Director,
Cardiovascular Research Group (CVRG), University of Saskatchewan, Canada
Speech Opportunity Available
Title: The Prognostic Impacts of Body Mass Index in Coronary Vascular Disease after
08:55-09:20
Coronary Artery Bypass Surgery
Dr. Jaw-Wen Chen, Professor, Institute of Pharmacology, National Yang-Ming University
School of Medicine, Taiwan
Title: Methylglyoxal, Vascular Dysfunction and Metabolic Syndrome
09:20-09:45
Dr. Lingyun Wu, Professor, Department of Pharmacology, College of Medicine; Director,
Cardiovascular Research Group (CVRG), University of Saskatchewan, Canada
09:45-10:10
Speech Opportunity Available
10:10-10:30
Coffee Break
MD508: Primary Immunodeficiencies and Immune Diseases
Day 3, 13:30-15:30, September 24, 2011
Chair:
13:30-13:55
Dr. Laszlo Marodi, Professor, Department of Infectious and Pediatric Immunology,
University of Debrecen Medical and Health Science Center, Hungary
Speech Opportunity Available
Title: Ryanodine receptors as a target for immunomodulation
13:55-14:20
Dr. Alla Fomina, Associate Professor, Department of Physiology and Membrane Biology
One Shields Ave, University of California at Davis, USA
Title: Paradoxical Immunity and Preventive Medicine
14:20-14:45
Dr. Olga Zhiangerova, Head of Lab. of Clinical Diagnostics, Medical Research Center
“Immunculus”, Russia
Title: Primary Genetic Defects of Immune Regulation
14:45-15:10
Dr. Laszlo Marodi, Professor, Department of Infectious and Pediatric Immunology,
University of Debrecen Medical and Health Science Center, Hungary
15:10-15:30
Coffee Break
MD509: Biomarkers for Autoimmune Diseases
Day 3, 13:30-15:30, September 24, 2011
Chair:
13:30-13:55
Dr. Ciriaco A. Piccirillo, Canada Research Chair and Associate Professor, Department
of Microbiology & Immunology and Medicine, Montreal General Hospital, Canada
Speech Opportunity Available
Title: Immune Dysfunction in Chronic and Autoimmune Disorders: Lessons from Mice
13:55-14:20
and Men
Dr. Ciriaco A. Piccirillo, Canada Research Chair and Associate Professor, Department
of Microbiology & Immunology and Medicine, Montreal General Hospital, Canada
Title: Two Important Discoveries
14:20-14:45
Dr. Gianfranco Bottazzo, Professor and Research Consultant, Ospedale Pediatrico
Bambino Gesù, Italy
14:45-15:10
Speech Opportunity Available
15:10-15:30
Coffee Break
Track MD6: Molecular Diagnositcs for Biopharmaceutical Industries and Healthcares
Day 1, 13:30-15:10, September 22, 2011
Track MD600: Molecular diagnostics in Biopharmaceutical Industry
Track MD601: MDx in Gene Therapy
Track MD602: Detecting Microbial Contamination In Biopharmaceutical Manufacturing
Track MD603: Molecular diagnostics for Organ Transplantation
Track MD604: MDx in Blood Screening of Epidemic Infectious Diseases
Track MD605: MDX in Sports and Food Toxins and Pathogens
Track MD606: Molecular Diagnostics at Hospital for Disease Management
Track MD607: Companion Diagnostics and Point-of-care Diagnosis (POC)
Chair:
13:30-13:55
Call for Chair
Speech Opportunity Available
Title: Ovarian Cancer Suicide Gene Therapy
13:55-14:20
Dr. Marek Malecki, Associate Professor of Genetics, Genomics, and Gene Therapy,
Director of Biotechnology Program, Western University of Health Sciences, USA
Title: Innovative Point-of-care Diagnostic Devices for Primary Health Care, the Center
14:20-14:45
for Care Technology Research Initiative
Dr. Geert-Jan Dinant, Professor of General Practice, Maastricht University, The
Netherlands
Title: A Peptide Mimotope as a Potential Diagnostic and Therapeutic Therapy in Organ
14:45-15:10
Transplantation
Dr. Jenny Chiang, Research Fellow, Kazusa Institute for Drug Discovery, Josai
International University, Japan
15:10-15:30
Coffee Break
Track MD7: Business Development on MD
Track MD7: Business Development on MD
Day 3, 08:30-12:10, September 24, 2011
MD700: Focus on Infectious Disease Testing
MD701: Focus on ID/Forensics Analysis
MD702: Focus on Tissue Typing Testing
MD703: Focus on Cancer Testing
MD704: Focus on Food Testing
MD705: Focus on Genetic Testing
The conference will feature this business forum to provide delegates many opportunities to meet and
discuss current issues. We welcome all the speakers and attendees to join this section to share the new
result of your current project.
Please contact
Chair:
: cemd2011@gmail.com
if you are interested in join the Section
Dr. Heather A. Valentine, Vice President, Global Sales, Informatics and Laboratory
Automation, Scientific Instruments Division, Thermo Fisher Scientific, USA
Title: Continuing Legislative Requirements and Emerging Trends in Global Food Testing
08:30-08:55
and Technologies to Support Compliance
Dr. Heather A. Valentine, Vice President, Global Sales, Informatics and Laboratory
Automation, Scientific Instruments Division, Thermo Fisher Scientific, USA
08:55-09:20
Speech Opportunity Available
Title: Study Design of Minitoring Studies
09:20-09:45
Dr. Georg Soletormos,Medical Director, Hillerod Hospital, University of Copenhagen,
Denmark
Title: Business Models in Molecular Diagnostics and Personalized Medicine: An
09:45-10:10
Evolving Paradigm
Dr. Kristin Ciriello Pothier, Partner, Health Advances, LLC, USA
10:10-10:30
Coffee Break
The Left of This Session is Under Development...
MD8: Young Scientist Forum
Day 3, 13:30-15:30, September 24, 2011
Chair:
Call for Chair
The Left of This Session is Under Development...